Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC2A1 | P11166 | 1/20 | 0.57 |
| ▸ | CSNK1E | P49674 | 1/20 | 0.49 |
| ▸ | HTR2A | P28223 | 2/20 | 0.46 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.43 |
| ▸ | SCN4A | P35499 | 2/20 | 0.42 |
| ▸ | HRH1 | P35367 | 1/20 | 0.42 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13132265 | 1.00 | SLC2A1 (0.57) | SLC2A1CSNK1EHTR2ASIGMAR1CA2 | |
| SCHEMBL10340961 | 0.98 | SLC2A1 (0.60) | SLC2A1CSNK1EHTR2ASIGMAR1CA2 | |
| SCHEMBL7734329 | 0.98 | SLC2A1 (0.60) | SLC2A1CSNK1EHTR2ASIGMAR1CA2 | |
| SCHEMBL3404678 | 0.98 | SLC2A1 (0.60) | SLC2A1CSNK1EHTR2ASIGMAR1CA2 | |
| SCHEMBL4080852 | 0.98 | SLC2A1 (0.60) | SLC2A1CSNK1EHTR2ASIGMAR1CA2 | |
| SCHEMBL3124987 | 0.98 | SLC2A1 (0.60) | SLC2A1CSNK1EHTR2ASIGMAR1CA2 | |
| SCHEMBL10589876 | 0.98 | SLC2A1 (0.60) | SLC2A1CSNK1EHTR2ASIGMAR1CA2 | |
| Hydrochloric Acid SCHEMBL4937477 | 0.98 | SLC2A1 (0.60) | SLC2A1CSNK1EHTR2ASIGMAR1CA2 | |
| SCHEMBL4071245 | 0.98 | SLC2A1 (0.60) | SLC2A1CSNK1EHTR2ASIGMAR1CA2 | |
| SCHEMBL4990564 | 0.98 | SLC2A1 (0.60) | SLC2A1CSNK1EHTR2ASIGMAR1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 183 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114671781-B | Method for converting arylbenzylamine into arylnitrile compound | 南通大学 | 2024-04-19 | — | — | CN | claimed |
| CN-114671781-A | Method for efficiently converting arylbenzylamine into aryl nitrile compound | 南通大学 | 2022-06-28 | — | — | CN | claimed |
| US-20220194969-A1 | METAL HALIDE PEROVSKITE LIGHT EMITTING DEVICE AND METHOD FOR MANUFACTURING SAME | SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION (KR) | 2022-06-23 | — | — | US | claimed |
| WO-2020130592-A1 | METAL HALIDE PEROVSKITE LIGHT EMITTING DEVICE AND METHOD FOR MANUFACTURING SAME | 서울대학교산학협력단 | 2020-06-25 | — | — | WO | claimed |
| CN-108610338-A | A kind of preparation method of Pyrimidone amide | 天津国际生物医药联合研究院 | 2018-10-02 | — | — | CN | claimed |
| EP-1586552-B1 | PROCESS FOR PRODUCING BENZYLAMINE DERIVATIVE | IHARA CHEMICAL IND CO (JP) | 2010-08-25 | — | — | EP | claimed |
| US-7326813-B2 | Process for producing benzylamine derivative | IHARA CHEMICAL INDUSTRY (JP) | 2008-02-05 | — | — | US | claimed |
| US-20060155141-A1 | Process for producing benzylamine derivative | ITO AKINORI | 2006-07-13 | — | — | US | claimed |
| EP-1586552-A1 | PROCESS FOR PRODUCING BENZYLAMINE DERIVATIVE | IHARA CHEMICAL INDUSTRY Co., Ltd. (JP) | 2005-10-19 | — | — | EP | claimed |
| CN-1063429-C | Preparation of arylbenzylamines | BASF AG (DE) | 2001-03-21 | — | — | CN | claimed |
| CN-1115754-A | Preparation of arylbenzylamines | BASF AG (DE) | 1996-01-31 | — | — | CN | claimed |
| US-12466789-B2 | Isothiocyanate functional surfactants, formulations incorporating the same, and associated methods of use | THE WILLIAM YARBROUGH FOUNDATION (US) | 2025-11-11 | — | — | US | disclosed |
| US-20250161258-A1 | ISOTHIOCYANATE FUNCTIONAL SURFACTANTS, FORMULATIONS INCORPORATING THE SAME, AND ASSOCIATED METHODS OF USE | THE WILLIAM M YARBROUGH FOUND (US) | 2025-05-22 | — | — | US | disclosed |
| US-12133525-B2 | Agricultural pesticide compositions | SPECIALTY OPERATIONS FRANCE (FR) | 2024-11-05 | — | — | US | disclosed |
| EP-4446310-A1 | METHOD FOR PRODUCING BLOCKED ISOCYANATE COMPOUND AND METHOD FOR PRODUCING ISOCYANATE COMPOUND | Asahi Kasei Kabushiki Kaisha (JP) | 2024-10-16 | — | — | EP | disclosed |
| US-5231209-A | Phenylhexyl isothiocyanate | AMERICAN HEALTH FOUNDATION (US) | 1993-07-27 | — | — | US | disclosed |
| US-5231209-A | Phenylhexyl isothiocyanate | AMERICAN HEALTH FOUNDATION (US) | 1993-07-27 | — | — | US | disclosed |
| US-5114969-A | Method of inhibiting lung tumors, arylalkyl isothiocyanates, and method of synthesizing same | AMERICAN HEALTH FOUNDATION (US) | 1992-05-19 | — | — | US | disclosed |
| US-5114969-A | Method of inhibiting lung tumors, arylalkyl isothiocyanates, and method of synthesizing same | AMERICAN HEALTH FOUNDATION (US) | 1992-05-19 | — | — | US | disclosed |
| US-4117159-A | ANTICHOLESTEROL, ANTIINFLAMMATORY, ANTIPYRETIC AGENTS | NIPPON SHINYAKU CO., LTD. (JP) | 1978-09-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220194969-A1 | METAL HALIDE PEROVSKITE LIGHT EMITTING DEVICE AND METHOD FOR MANUFACTURING SAME | HCN4, SLC46A1, FES | SLC2A1 335/4885CSNK1E 4602/4885HTR2A 853/4885 |
| US-20060155141-A1 | Process for producing benzylamine derivative | BRD7, BRD1, BRD2 | SLC2A1 3039/4885CSNK1E 2143/4885HTR2A 1550/4885 |
| US-12466789-B2 | Isothiocyanate functional surfactants, formulations incorporating the same, and associated methods of use | F12, MSR1, TST | SLC2A1 759/4885CSNK1E 550/4885HTR2A 2852/4885 |
| US-20250161258-A1 | ISOTHIOCYANATE FUNCTIONAL SURFACTANTS, FORMULATIONS INCORPORATING THE SAME, AND ASSOCIATED METHODS OF USE | TST, TMSB10, NHERF1 | SLC2A1 1128/4885CSNK1E 511/4885HTR2A 4604/4885 |
| US-12133525-B2 | Agricultural pesticide compositions | SGMS2, DDT, SGMS1 | SLC2A1 2623/4885CSNK1E 4827/4885HTR2A 633/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.